BCAT1
Transaminaza 1 razgranatih aminokiselinskih lanaca je protein-enzim koji je kod ljudi kodiran genom BCAT1.[5] To je prvi enzim na putu razgradnje aminokiselina razgranatog lanca (BCAA) i olakšava reverzibilnu transaminaciju BCAA i glutamata. BCAT1 se nalazi u citoplazmi, dok se njegova izoforma, BCAT2 nalazi u mitohondrijama.
Aminokiselinska sekvenca
urediDužina polipeptidnog lanca je 386 aminokiselina, a molekulska težina 42.966 Da.[6].
10 | 20 | 30 | 40 | 50 | ||||
---|---|---|---|---|---|---|---|---|
MKDCSNGCSA | ECTGEGGSKE | VVGTFKAKDL | IVTPATILKE | KPDPNNLVFG | ||||
TVFTDHMLTV | EWSSEFGWEK | PHIKPLQNLS | LHPGSSALHY | AVELFEGLKA | ||||
FRGVDNKIRL | FQPNLNMDRM | YRSAVRATLP | VFDKEELLEC | IQQLVKLDQE | ||||
WVPYSTSASL | YIRPTFIGTE | PSLGVKKPTK | ALLFVLLSPV | GPYFSSGTFN | ||||
PVSLWANPKY | VRAWKGGTGD | CKMGGNYGSS | LFAQCEAVDN | GCQQVLWLYG | ||||
EDHQITEVGT | MNLFLYWINE | DGEEELATPP | LDGIILPGVT | RRCILDLAHQ | ||||
WGEFKVSERY | LTMDDLTTAL | EGNRVREMFG | SGTACVVCPV | SDILYKGETI | ||||
HIPTMENGPK | LASRILSKLT | DIQYGREESD | WTIVLS |
Funkcija
urediOvaj gen kodira citosolni oblik enzim transaminaze aminokiselina razgranatog lanca. Ovaj enzim katalizira reverzibilne transaminacije alfa-keto kiselina razgranatog lanca (BCKA) u aminokiseline razgranatog lanca (BCAA) valin, leucin i izoleucin , koji su neophodni za rast ćelija. Kod ljudi, njegova primarna uloga je deaminacija BCAA, jer im nedostaju enzimi za sintezu BCKA de novo. Odgovarajući kofaktori su alfa-ketoglutarat i glutamat. Odgovarajuće reakcije su:
- L-leucin + 2-oksoglutarat = 4-metil-2-oksopentanoat + L-glutamat
- L-izoleucin + 2-oksoglutarat = (S)-3-metil-2-oksopentanoat + L-glutamat
- L-valin + 2-oksoglutarat = 3-metil-2-oksobutanoat + L-glutamat[7]
Ćelije mogu dalje razgraditi BCKA pomoću kompleksa dehidrogenaze keto-kiseline s razgranatim lancem iz kojeg ugljikove okosnice svakog BCAA mogu ući u različite puteve razgradnje.[8]
Često se izvještava da onkogeni transkripcijski faktor Myc podstiče ekspresiju BCAT1.[9][10][11]
Klinički značaj
urediDva različita klinička poremećaja pripisana su defektu transaminacije aminokiselina razgranatog lanca: hipervalinemija i hiperleucin-izoleucinemija.[12] Budući da postoji i gen koji kodira mitohondrijski oblik ovog enzima (BCAT2), mutacije oba gena mogu pridonijeti ovim poremećajima.
Prekomjerna ekspresija BCAT1 povezana je s različitim tipovima karcinoma, među njima glioblastomom,[13] rakom dojke,[14] akutnom mijeloidnom leukemijom,[15] rakom želuca[16] i hroničnom mijeloidnom leukemijom.[17]
Reference
uredi- ^ a b c GRCh38: Ensembl release 89: ENSG00000060982 - Ensembl, maj 2017
- ^ a b c GRCm38: Ensembl release 89: ENSMUSG00000030268 - Ensembl, maj 2017
- ^ "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
- ^ "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
- ^ "Entrez Gene: Branched chain amino acid transaminase 1". Pristupljeno 21. 4. 2016.
- ^ "UniProt, P54687". Pristupljeno 7. 8. 2021.
- ^ "BCAT1 - Branched-chain-amino-acid aminotransferase, cytosolic - Homo sapiens (Human) - BCAT1 gene & protein". www.uniprot.org (jezik: engleski). Pristupljeno 6. 8. 2018.
- ^ "BCKDH in the BCAA degradation pathway". Genome.jp. 6. 8. 2018. Pristupljeno 6. 8. 2018.
- ^ Zhou W, Feng X, Ren C, Jiang X, Liu W, Huang W, Liu Z, Li Z, Zeng L, Wang L, Zhu B, Shi J, Liu J, Zhang C, Liu Y, Yao K (juni 2013). "Over-expression of BCAT1, a c-Myc target gene, induces cell proliferation, migration and invasion in nasopharyngeal carcinoma". Molecular Cancer. 12: 53. doi:10.1186/1476-4598-12-53. PMC 3698204. PMID 23758864.
- ^ Schuldiner O, Eden A, Ben-Yosef T, Yanuka O, Simchen G, Benvenisty N (juli 1996). "ECA39, a conserved gene regulated by c-Myc in mice, is involved in G1/S cell cycle regulation in yeast". Proceedings of the National Academy of Sciences of the United States of America. 93 (14): 7143–8. Bibcode:1996PNAS...93.7143S. doi:10.1073/pnas.93.14.7143. PMC 38950. PMID 8692959.
- ^ Ben-Yosef T, Eden A, Benvenisty N (juli 1998). "Characterization of murine BCAT genes: Bcat1, a c-Myc target, and its homolog, Bcat2". Mammalian Genome. 9 (7): 595–7. doi:10.1007/s003359900825. PMID 9657861. S2CID 21062787.
- ^ Wang XL, Li CJ, Xing Y, Yang YH, Jia JP (septembar 2015). "Hypervalinemia and hyperleucine-isoleucinemia caused by mutations in the branched-chain-amino-acid aminotransferase gene". Journal of Inherited Metabolic Disease. 38 (5): 855–61. doi:10.1007/s10545-015-9814-z. PMID 25653144. S2CID 24253640.
- ^ Tönjes M, Barbus S, Park YJ, Wang W, Schlotter M, Lindroth AM, et al. (juli 2013). "BCAT1 promotes cell proliferation through amino acid catabolism in gliomas carrying wild-type IDH1". Nature Medicine. 19 (7): 901–908. doi:10.1038/nm.3217. PMC 4916649. PMID 23793099.
- ^ Thewes V, Simon R, Hlevnjak M, Schlotter M, Schroeter P, Schmidt K, et al. (juli 2017). "The branched-chain amino acid transaminase 1 sustains growth of antiestrogen-resistant and ERα-negative breast cancer". Oncogene. 36 (29): 4124–4134. doi:10.1038/onc.2017.32. PMID 28319069. S2CID 25098058.
- ^ Raffel S, Falcone M, Kneisel N, Hansson J, Wang W, Lutz C, et al. (novembar 2017). "BCAT1 restricts αKG levels in AML stem cells leading to IDHmut-like DNA hypermethylation". Nature. 551 (7680): 384–388. Bibcode:2017Natur.551..384R. doi:10.1038/nature24294. PMID 29144447. S2CID 205261267.
- ^ Xu Y, Yu W, Yang T, Zhang M, Liang C, Cai X, Shao Q (maj 2018). "Overexpression of BCAT1 is a prognostic marker in gastric cancer". Human Pathology. 75: 41–46. doi:10.1016/j.humpath.2018.02.003. PMID 29447920.
- ^ Hattori A, Tsunoda M, Konuma T, Kobayashi M, Nagy T, Glushka J, Tayyari F, McSkimming D, Kannan N, Tojo A, Edison AS, Ito T (maj 2017). "Cancer progression by reprogrammed BCAA metabolism in myeloid leukaemia". Nature. 545 (7655): 500–504. Bibcode:2017Natur.545..500H. doi:10.1038/nature22314. PMC 5554449. PMID 28514443.
Dopunska literatura
uredi- Yoshikawa R, Yanagi H, Shen CS, Fujiwara Y, Noda M, Yagyu T, Gega M, Oshima T, Yamamura T, Okamura H, Nakano Y, Morinaga T, Hashimoto-Tamaoki T (septembar 2006). "ECA39 is a novel distant metastasis-related biomarker in colorectal cancer". World Journal of Gastroenterology. 12 (36): 5884–9. doi:10.3748/wjg.v12.i36.5884. PMC 4100673. PMID 17007058.